BIOBRITE LIMITED
Significant control: Ramchandra Padmakar Sadigale (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Biobrite Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Biobrite Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
BIOBRITE LIMITED is an active private limited company (company number 13077020) incorporated on 11 December 2020, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £141, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 5% on the prior period (£134). Across the last 3 periods on record the net-asset trend is rising.
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Mr Ramchandra Padmakar Sadigale
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 11 December 20205 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 25 December 2026in 61 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- SIC 82990
- Other business support service activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £141 | — | — | £600 | — | — | 1 |
| 31 December 2024 | £134 | — | — | £778 | — | — | 1 |
| 31 December 2023 | £128 | — | — | £687 | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £141 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.07
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 11 December 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 61 days
- Accounts period endNet assets £141 · micro accounts
- Accounts period endNet assets £134 · micro accounts
- Accounts period endNet assets £128 · micro accounts
- Incorporated
Similar companies in London
- VALINK THERAPEUTICS LTDLondon · inc. Dec 2020
- DANTE GENOME HOUSE LTDLondon · inc. Dec 2020
- HUMAN CENTRIC DD LTDLondon · inc. Dec 2020
- LECHLER LOMBARDI CONSULTING LIMITEDLondon · inc. Dec 2020
- APEIKON THERAPEUTICS LTDLondon · inc. Dec 2020
- EUPNOOS LTDLondon · inc. Dec 2020
All companies incorporated on 11 December 2020 · in Dec 2020.
Reminders for BIOBRITE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.